Medications for Stent Thrombosis

3 results

  • brilinta - ticagrelor tablet

    (Ticagrelor)
    Astrazeneca Pharmaceuticals Lp
    Brilinta reduces the risk of cardiovascular death, heart attack, and stroke in patients with acute coronary syndrome or prior heart attack. It also lowers the risk of first heart attack or stroke in high-risk coronary artery disease patients, and reduces stroke risk after mild ischemic stroke or high-risk TIA.
    Medication Details
    Drug Interactions

  • kengreal - cangrelor injection, powder, lyophilized, for solution

    (Cangrelor)
    Chiesi Usa, Inc.
    Kengreal is used during percutaneous coronary intervention (PCI) to reduce the risk of heart attack, repeat revascularization, and stent thrombosis in patients not previously treated with a P2Y12 inhibitor or glycoprotein IIb/IIIa inhibitor.
    Medication Details
    Drug Interactions